Piper Sandler Maintains Overweight on Organon, Lowers Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Amsellem has maintained an Overweight rating on Organon (NYSE:OGN) but reduced the price target from $32 to $22.
November 22, 2023 | 5:52 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler has maintained an Overweight rating on Organon but lowered the price target from $32 to $22, indicating a potential downside compared to the previous target.
The reduction in price target by Piper Sandler suggests that they see less upside potential for Organon's stock price in the short term. This could lead to a negative investor sentiment and a potential decrease in the stock price as the market adjusts to the new target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100